158 related articles for article (PubMed ID: 6381689)
1. Preformulation method for parenteral preservative efficacy evaluation.
Akers MJ; Boand AV; Binkley DA
J Pharm Sci; 1984 Jul; 73(7):903-5. PubMed ID: 6381689
[TBL] [Abstract][Full Text] [Related]
2. Changes in preservative sensitivity for the USP antimicrobial agents effectiveness test micro-organisms.
Al-Hiti MM; Gilbert P
J Appl Bacteriol; 1980 Aug; 49(1):119-26. PubMed ID: 7429998
[No Abstract] [Full Text] [Related]
3. Preservation of solubilized and emulsified systems I: Correlation of mathematically predicted preservative availability with antimicrobial activity.
Kazmi SJ; Mitchell AG
J Pharm Sci; 1978 Sep; 67(9):1260-6. PubMed ID: 357702
[TBL] [Abstract][Full Text] [Related]
4. Optimising concentrations of antimicrobial agents in pharmaceutical preparations: Case of an oral solution of glycerol and an ophthalmic solution containing cysteamine.
Chan Hew Wai A; Becasse P; Tworski S; Pradeau D; Planas V
Ann Pharm Fr; 2014 Nov; 72(6):415-21. PubMed ID: 25438652
[TBL] [Abstract][Full Text] [Related]
5. Comparison of contamination rates between preserved and preservative-free fluoroquinolone eyedrops.
Kim MS; Kim HK; Kim JM; Choi CY
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):817-24. PubMed ID: 23064697
[TBL] [Abstract][Full Text] [Related]
6. Effects of preservatives, steroids, and ethylenediaminetetraacetate on the antimicrobial activity of sulfacetamide.
Houlsby RD; Ghajar M; Chavez L
J Pharm Sci; 1983 Dec; 72(12):1401-3. PubMed ID: 6420538
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of preservative systems in opthalmic suspension of polymyxin B and dexamethasone by linear regression.
Bou-Chacra NA; Pinto TJ; Kaneko TM
Pharmazie; 2007 Mar; 62(3):199-204. PubMed ID: 17416196
[TBL] [Abstract][Full Text] [Related]
8. [The use of preservatives in skin preparations].
Van Ooteghem M
Pharmazie; 1984 Sep; 39(9):621-5. PubMed ID: 6504999
[TBL] [Abstract][Full Text] [Related]
9. Attempted measurement of the activity of selected preservative combinations.
McCarthy TJ; Ferreira JH
J Clin Pharm Ther; 1990 Apr; 15(2):123-9. PubMed ID: 2187891
[TBL] [Abstract][Full Text] [Related]
10. [Low-level challenge test for the examination of the microbiological susceptibility, during the period of use, of liquid and semi-solid dosage forms in multiple-dose containers (author's transl)].
Urban S; Hecker W; Schiller I
Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 172(6):478-84. PubMed ID: 7257652
[TBL] [Abstract][Full Text] [Related]
11. Preservation of solubilized and emulsified systems II: Theoretical development of capacity and its role in antimicrobial activity of chlorocresol in cetomacrogol-stabilized systems.
Kazmi SJ; Mitchell AG
J Pharm Sci; 1978 Sep; 67(9):1266-71. PubMed ID: 690832
[TBL] [Abstract][Full Text] [Related]
12. Microbial contamination of a vitamin A formulation, prepared in local pharmacies, and its preservation against yeasts and moulds.
van Doorne H; Scheffers WA; Hadiutomo M; van den Bosch E
Antonie Van Leeuwenhoek; 1984; 50(4):405-16. PubMed ID: 6524914
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of preservative efficacy in pharmaceutical products: the use of psychrotolerant, low-nutrient preferring microbes in challenge tests.
Charnock C; Otterholt E
J Clin Pharm Ther; 2012 Oct; 37(5):558-64. PubMed ID: 22591271
[TBL] [Abstract][Full Text] [Related]
14. Development of the antimicrobial effectiveness test as USP chapter <51>.
Sutton SV; Porter D
PDA J Pharm Sci Technol; 2002; 56(6):300-11. PubMed ID: 12497767
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of a preservative system in an oily preparation.
De Spiegeleer B; Wattyn E; Slegers G; Veys P; Derrieu G; Van Vooren L
Pharmazie; 2006 Jun; 61(6):545-51. PubMed ID: 16826975
[TBL] [Abstract][Full Text] [Related]
16. Effects of time, temperature, and preservative on bacterial growth in enteral nutrient solutions.
Fagerman KE; Paauw JD; McCamish MA; Dean RE
Am J Hosp Pharm; 1984 Jun; 41(6):1122-6. PubMed ID: 6430069
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of disinfection of selected preservatives against Escherichia coli.
Hurwitz SJ; McCarthy TJ
J Pharm Sci; 1985 Aug; 74(8):892-4. PubMed ID: 3897510
[TBL] [Abstract][Full Text] [Related]
18. Microbiological standards for nasal solutions.
Moore KE; Taylor JE
J Appl Bacteriol; 1976 Dec; 41(3):379-87. PubMed ID: 65350
[No Abstract] [Full Text] [Related]
19. Preservative activity in diluted corticosteroid creams.
Hugo WB; Denyer SP; York HL; Tucker JD
J Hosp Infect; 1984 Sep; 5(3):329-33. PubMed ID: 6208253
[TBL] [Abstract][Full Text] [Related]
20. Microbial contamination and preservative efficacy of topical creams.
Na'was T; Alkofahi A
J Clin Pharm Ther; 1994 Feb; 19(1):41-6. PubMed ID: 8188790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
